https://www.selleckchem.com/products/gsk046.html
7.3% (4/55), χ²=4.862, P=0.027), and higher rate of renal replacement therapy (48.1% (26/54) vs. 21.8% (12/55), χ²=9.694, P=0.008) during ECMO support. Logistic regression analysis showed that continuous renal replacement therapy (CRRT) and AKI were independent risk factors for death in patients with severe PARDS requiring ECMO support (HR=3.88,95%CI 1.04-14.52, HR=4.84,95%CI 1.21-19.46, both P less then 0.05). Conclusion AKI and CRRT are independent risk factors for predicting mortality in patients with severe PARDS requiring ECMO suppo
Tycka om
Kommentar
Dela med sig
